Latest Commercial Contracts News

Green360 Technologies has secured its first binding commercial supply agreement with Holcim Australia for up to 4,800 tonnes of its proprietary MKX-CC low-carbon cement replacement, marking a significant step from development to commercial sales amid tightening supplementary cementitious material supplies.

Papyrus Australia has tapped related party L39 Capital to lead a capital raise and secured an interest-bearing $200,000 loan from Irwin Biotech, with conversion into shares and options pending shareholder approval.

Norwood Systems lifted FY26 customer cash receipts to a record A$2.327 million, driven by multiple Tier-1 carrier contracts and successful AI pilot completions in Australia and the UK.

NH3 Clean Energy (ASX:NH3) has updated investors on its WAH2 Project, aiming for commercial operations by 2030 to produce low-emissions ammonia for Asia-Pacific markets. The presentation highlights strategic advantages, partnerships, and a phased development plan amid ongoing contract and financing negotiations.

Memphasys delivered a record $150,000 quarterly revenue, secured its largest Felix™ supply contract with Monash IVF, and expanded into UK and Southeast Asian IVF markets, positioning for accelerated growth in FY27.

Zoono Group has reported a 94% jump in quarterly cash receipts to NZ$975K, turning cash flow positive amid expanding commercial rollouts of its shelf-life extension technology across multiple continents.

Swift TV has landed a second multi-site hospitality contract, expanding its footprint in premium Western Australian accommodation and reinforcing its recurring revenue model.

Dataworks Group has arranged a $1.5 million unsecured working capital facility with a three-month term and 18% interest, aiming to strengthen liquidity and support ongoing and new commercial contracts without diluting equity.

Calix's subsidiary Leilac has locked in a paid engineering study with an East Asian cement producer, advancing its commercial cement decarbonisation technology without capital outlay. This complements its recent Indian partnership and signals a strategic pivot to capital-light projects.

CONNEQT Health has raised A$5.5 million through a two-tranche placement at a 15.4% discount, backed by key shareholders, to accelerate its commercial expansion and product development.

Memphasys has secured $1.2 million through a share placement to support the global expansion and manufacturing scale-up of its Felix™ sperm selection system. The company also extended a major convertible note, reinforcing financial flexibility amid growing international contracts.

Electro Optic Systems’ MARSS division has been tapped by BAE Systems to provide the AI-driven command and control platform for its new Anti Threat System, a major step in global counter-drone defence.